Nucleus Raphe Pallidus
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Nucleus Raphe Pallidus Expanded</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0020003](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0020003)</td>
</tr>
</table>
Overview
flowchart TD
Nucleus["Nucleus"] -->|"component of"| Genome_Packaging["Genome Packaging"]
NUCLEUS["NUCLEUS"] -->|"activates"| ENDOPLASMIC_RETICULUM["ENDOPLASMIC RETICULUM"]
NUCLEUS["NUCLEUS"] -->|"associated with"| INTERNEURONS["INTERNEURONS"]
NUCLEUS["NUCLEUS"] -->|"associated with"| AMYGDALA["AMYGDALA"]
NUCLEUS["NUCLEUS"] -->|"associated with"| HEPATOCYTES["HEPATOCYTES"]
NUCLEUS["NUCLEUS"] -->|"interacts with"| HEPATOCYTES["HEPATOCYTES"]
NUCLEUS["NUCLEUS"] -->|"associated with"| CEREBRAL_CORTEX["CEREBRAL CORTEX"]
NUCLEUS["NUCLEUS"] -->|"associated with"| TEMPORAL_LOBE["TEMPORAL LOBE"]
NUCLEUS["NUCLEUS"] -->|"inhibits"| SRPK1["SRPK1"]
NUCLEUS["NUCLEUS"] -->|"activates"| SRPK1["SRPK1"]
NUCLEUS["NUCLEUS"] -->|"interacts with"| INTERNEURONS["INTERNEURONS"]
n3D_genome_organization["3D genome organization"] -->|"involved in"| nucleus["nucleus"]
CHMP2BIn5["CHMP2BIn5"] -->|"associated with"| nucleus["nucleus"]
Inter_chromosomal_Hubs["Inter-chromosomal Hubs"] -->|"component of"| Nucleus["Nucleus"]
style NUCLEUS fill:#4fc3f7,stroke:#333,color:#000
...Nucleus Raphe Pallidus
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Nucleus Raphe Pallidus Expanded</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0020003](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0020003)</td>
</tr>
</table>
Overview
Mermaid diagram (expand to render)
Nucleus Raphe Pallidus Expanded plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
<!-- multi-taxonomy-enrichment -->
Multi-Taxonomy Classification
Taxonomy Database Cross-References
Morphology & Electrophysiology
- Morphology: internal globus pallidus core projecting neuron (source: Cell Ontology)
- Morphology can be inferred from Cell Ontology classification
External Database Links
- [Cell Ontology (CL:0020003)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0020003)
- [OBO Foundry (CL:0020003)](http://purl.obolibrary.org/obo/CL_0020003)
- [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
- [CellxGene Census](https://cellxgene.cziscience.com/)
- [Human Cell Atlas](https://www.humancellatlas.org/)
Introduction
The nucleus raphe pallidus (NRP) is a medullary raphe nucleus located in the ventral medulla oblongata. As part of the serotoninergic brainstem system, the NRP plays critical roles in autonomic regulation, motor control, pain modulation, and thermoregulation. Dysfunction of the NRP is implicated in various neurodegenerative diseases, particularly those affecting serotoninergic pathways. [@muller2022]
Anatomy and Structure
Location and Boundaries
The nucleus raphe pallidus is situated in the ventral medulla, midline raphe region. It extends from the level of the inferior olive to the rostral medulla, and is bounded: [@rochat2021]
- Dorsally by the nucleus raphe magnus (NRM)
- Laterally by the gigantocellular reticular nucleus (Gi)
- Ventrally by the pyramids (corticospinal tracts)
- Rostrally by the pontine raphe nucleus
- Caudally by the spinal trigeminal nucleus
Cellular Composition
The NRP contains predominantly serotoninergic (5-HT) neurons along with non-serotoninergic cells: [@taylor2022]
Serotoninergic (5-HT) Neurons: Tryptophan hydroxylase 2 (TPH2)-positive neurons that project to spinal cord and forebrain
GABAergic Neurons: Local interneurons that modulate raphe output
Glutamatergic Neurons: Excitatory neurons using glutamate as a transmitter
Parvalbumin-Expressing Neurons: Calcium-binding protein containing neuronsMolecular Markers
Key molecular markers in the NRP include: [@benshachar2020]
- Tryptophan Hydroxylase 2 (TPH2): Rate-limiting enzyme for serotonin synthesis
- Serotonin Transporter (SERT): Reuptake of serotonin from synapse
- Vesicular Monoamine Transporter 2 (VMAT2): Packaging of serotonin into vesicles
- 5-HT1A Receptor: Autoreceptor controlling neuron firing
- 5-HT1B Receptor: Presynaptic autoreceptor
- 5-HT2 Receptor: Postsynaptic receptor for varied functions
- Pet-1: Transcription factor specifying 5-HT neurons
Connectivity and Function
The NRP receives input from: [@miller2021]
- Hypothalamus: Thermoregulatory and circadian signals
- Preoptic area: Sleep-wake regulation
- Parabrachial nucleus: Visceral sensory information
- Nucleus of the solitary tract: Cardiorespiratory integration
- Limbic system: Emotional processing
Efferent Outputs
The NRP projects extensively to: [@azmitia2019]
- Spinal Cord Dorsal Horn: Pain modulation
- Spinal Cord Ventral Horn: Motor neuron modulation
- Thalamus: Sensory processing
- Hypothalamus: Autonomic integration
- Basal Ganglia: Motor control
- Limbic Structures: Emotional regulation
Functions
Pain Modulation: Descending inhibition of nociceptive transmission in dorsal horn
Thermoregulation: Control of brown adipose tissue thermogenesis
Motor Control: Modulation of spinal motor neurons and movement
Autonomic Regulation: Cardiovascular and respiratory control
Sleep-Wake Cycling: Part of the ascending arousal system
Mood Regulation: Serotoninergic transmission affecting depression and anxietyRole in Neurodegenerative Diseases
Parkinson's Disease
The NRP shows significant changes in PD: [@michelsen2022]
Serotoninergic Degeneration: 5-HT neuron loss in raphe nuclei correlates with non-motor symptoms
Motor Fluctuations: NRP dysfunction contributes to levodopa-induced dyskinesias
Sleep Disorders: Disrupted serotonergic signaling affects sleep architecture
Mood Disorders: Depression in PD linked to raphe dysfunctionTherapeutic Implications:
- Serotoninergic agents may improve mood and sleep in PD
- Targeting 5-HT1A receptors can reduce dyskinesias
- Deep brain stimulation affects raphe-serotoninergic circuits
Alzheimer's Disease
NRP involvement in AD includes:
Serotonin Deficiency: Reduced 5-HT in cortical and hippocampal regions
Sleep Disturbances: Disrupted circadian serotonergic regulation
Mood Symptoms: Depression and anxiety associated with raphe dysfunction
Cognitive Function: 5-HT modulation of learning and memoryAmyotrophic Lateral Sclerosis (ALS)
Serotonin Dysregulation: Altered 5-HT signaling in ALS
Motor Neuron Excitability: NRP modulation of hyperexcitability
Autonomic Dysfunction: Contributing to cardiovascular instability
Respiratory Control: NRP involvement in breathing regulationOther Neurodegenerative Disorders
- Multiple System Atrophy: Serotoninergic dysfunction in autonomic failure
- Progressive Supranuclear Palsy: Raphe involvement in mood and sleep symptoms
- Frontotemporal Dementia: Serotonergic changes affecting behavior
Research Directions
Emerging Topics
Raphe-Striatal Interactions: Serotonin modulation of basal ganglia in movement disorders
Optogenetics: Selective manipulation of NRP neuron subtypes
Biomarkers: Raphe serotonin imaging as a disease marker
Neuroimmunomodulation: Serotonin effects on neuroinflammationKey Experimental Findings
- 5-HT1A agonists reduce parkinsonian symptoms in animal models
- NRP stimulation enhances motor recovery after lesions
- Serotonin protects against excitotoxic cell death
- Raphe dysfunction precedes motor symptoms in PD models
- [Brainstem — Main brainstem structure](/brain-regions/brainstem)
- [Raphe Nuclei — Related raphe structures](/genes/rel)
- [Parkinson's Disease — Primary disease with raphe involvement](/genes/ar)
- [Alzheimer's Disease — AD and serotonin dysfunction](/genes/dysf)
- [Serotonin System — Neurotransmitter details](/genes/ran)
Overview
Nucleus Raphe Pallidus Expanded plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Nucleus Raphe Pallidus Expanded has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
- [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
azmitia2019, Azmitia and Whitaker, Raphe serotonin neurons in aging (2019) (2019)
benshachar2020, Raphe nuclei in Alzheimer's disease (2020) (2020)
hornung2023, Hornung, The human raphe nuclei (2023) (2023)
michelsen2022, Optogenetic control of raphe neurons (2022) (2022)
miller2021, Descending pain modulation from raphe (2021) (2021)
muller2022, Muller and Jacobs, Serotonin system in Parkinson's disease (2022) (2022)
rochat2021, Raphe pallidus and autonomic control (2021) (2021)
taylor2022, Serotonin and neurodegeneration (2022) (2022)
Pathway Diagram
The following diagram shows the key molecular relationships involving Nucleus Raphe Pallidus Expanded discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)